MedPath

成都诺迪康生物制药有限公司

Ownership
-
Established
2000-12-15
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

5

NMPA:5

Drug Approvals

诺迪康口服液

Approval Number
国药准字Z20044398
Approval Date
Apr 20, 2023
NMPA

金石感冒茶

Approval Number
国药准字Z20025719
Approval Date
Mar 9, 2023
NMPA

小青龙胶囊

Approval Number
国药准字Z10970024
Approval Date
Mar 9, 2023
NMPA

Recombinant Human Brain Natriuretic Peptide for Injection

Product Name
新活素
Approval Number
国药准字S20050033
Approval Date
Jul 13, 2020
NMPA

舒胸胶囊

Approval Number
国药准字Z10980031
Approval Date
Oct 17, 2014
NMPA

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath